---
title: "Vertex Pharmaceuticals (VRTX) Receives a Buy from BMO Capital"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296223201.md"
description: "BMO Capital analyst Evan Seigerman maintained a Buy rating on Vertex Pharmaceuticals (VRTX) with a $600 price target, up from the current close of $515.55. The broader analyst consensus remains a Strong Buy with an average target of $565.32, implying 9.65% upside. Additionally, RBC Capital recently reiterated a Buy rating with a $570 target."
datetime: "2026-08-18T11:37:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296223201.md)
  - [en](https://longbridge.com/en/news/296223201.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296223201.md)
generator: "portal-rs"
---

# Vertex Pharmaceuticals (VRTX) Receives a Buy from BMO Capital

BMO Capital analyst Evan Seigerman maintained a Buy rating on Vertex Pharmaceuticals yesterday and set a price target of $600.00. The company’s shares closed yesterday at $515.55.

### Summer Sale - Claim 70% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Seigerman covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Novo Nordisk, and Pfizer. According to TipRanks, Seigerman has an average return of 10.7% and a 59.19% success rate on recommended stocks. 

Currently, the analyst consensus on Vertex Pharmaceuticals is a Strong Buy with an average price target of $565.32, implying a 9.65% upside from current levels. In a report released on August 12, RBC Capital also maintained a Buy rating on the stock with a $570.00 price target.

### Related Stocks

- [VRTX.US](https://longbridge.com/en/quote/VRTX.US.md)
- [BMO.US](https://longbridge.com/en/quote/BMO.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [RY.US](https://longbridge.com/en/quote/RY.US.md)

## Related News & Research

- [Clal Insurance Enterprises Holdings Ltd Buys Shares of 2,019 Vertex Pharmaceuticals Incorporated $VRTX](https://longbridge.com/en/news/296756674.md)
- [Callan Family Office LLC Buys New Position in Vertex Pharmaceuticals Incorporated $VRTX](https://longbridge.com/en/news/296677120.md)
- [The Bull Case For Vertex (VRTX) Could Change Following Upgraded 2026 Guidance And Pipeline Momentum - Learn Why](https://longbridge.com/en/news/296583461.md)
- [Osmosis Investment Management UK Ltd Acquires Shares of 21,075 Vertex Pharmaceuticals Incorporated $VRTX](https://longbridge.com/en/news/296771760.md)
- [TFR Capital LLC. Takes Position in Vertex Pharmaceuticals Incorporated $VRTX](https://longbridge.com/en/news/296021261.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**